Single vs Repeated Treatment with the Intragastric Balloon: A 5-Year Weight Loss Study

Abstract

Background

Saline-filled intragastric balloons (IB) may be inserted for 6 months to promote weight loss. We aimed to assess potential benefits of repeating IB therapy.

Methods

One hundred eighteen consecutive subjects (median body mass index, 34.0 kg/m2; interquartile range [IQR], 31.2–36.9) treated with IB were included in a prospective non-randomized multicenter study.

Results

Nineteen (16%) subjects had repeat IB therapy at their own request, either to prolong first treatment (n = 8) or after a IB-free interval (n = 11). Higher weight loss 3 months after first IB insertion independently predicted repeat therapy (P = 0.008). Median weight loss in subjects who had repeat therapy was lower with second vs first IB (9.0 vs 14.6 kg; 30.4% vs 49.3% excess weight [EW]; P = 0.003). Compared to subjects with single treatment (n = 99), those with repeat treatment (n = 19) had greater weight loss at first IB extraction (14.6 vs 11.0 kg; 49.3% vs 30.7% EW; P = 0.026) and 1 year later (12.0 vs 6.0 kg; 40.9% vs 20.8% EW; P = 0.008) but the difference became less than 2 kg starting at 3 years. At final follow-up (4.9 years; IQR, 3.4–6.7), the whole subject population had lost a median of 2.0 kg (IQR, −3.0 to 10.3) or 6.2% EW (IQR, −8.1 to 31.6) and identical proportions of subjects with single/repeat treatment had ≥10% baseline weight loss (26%) or bariatric surgery (32%).

Conclusion

Higher weight loss at 3 months independently predicted repeat IB therapy; weight loss with the second IB was lower compared to first IB. Repeat treatment had no effect on proportions of subjects with ≥10% baseline weight loss or bariatric surgery at final follow-up.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

Abbreviations

BMI:

body mass index

IB:

intragastric balloon

IQR:

interquartile range

LOCF:

last observation carried forward

References

  1. 1.

    Dumonceau JM. Evidence-based review of the bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.

    Article  PubMed  Google Scholar 

  2. 2.

    Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30:129–33.

    Article  CAS  Google Scholar 

  3. 3.

    Martinez-Brocca MA, Belda O, Parejo J, et al. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes Surg. 2007;17:649–57.

    Article  PubMed  Google Scholar 

  4. 4.

    Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.

    Article  PubMed  Google Scholar 

  5. 5.

    National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6 Suppl 2:51S–209.

    Google Scholar 

  6. 6.

    Zago S, Kornmuller AM, Agagliati D, et al. Benefit from bio-enteric Intra-gastric balloon (BIB) to modify lifestyle and eating habits in severely obese patients eligible for bariatric surgery. Minerva Med. 2006;97:51–64.

    CAS  PubMed  Google Scholar 

  7. 7.

    Lorentz FH. Der konstitutionsindex der frau. Klin Wochenshr. 1929;16:734–6.

    Article  Google Scholar 

  8. 8.

    Doldi SB, Micheletto G, Perrini MN, et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg. 2002;12:583–7.

    Article  CAS  PubMed  Google Scholar 

  9. 9.

    Francica G, Giardiello C, Iodice G, et al. Ultrasound as the imaging method of choice for monitoring the intragastric balloon in obese patients: normal findings, pitfalls and diagnosis of complications. Obes Surg. 2004;14:833–7.

    Article  PubMed  Google Scholar 

  10. 10.

    Douketis JD, Macie C, Thabane L, et al. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes. 2005;29:1153–67.

    Article  CAS  Google Scholar 

  11. 11.

    Dansinger ML, Tatsioni A, Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147:41–50.

    PubMed  Google Scholar 

  12. 12.

    Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005;143:251–64.

    PubMed  Google Scholar 

  13. 13.

    Machytka E, Klvana P, Hanuskova L, et al. Use of pharmacotherapy for long-term maintenance of weight loss following explantation of intragastric balloon (BIB). Gut. 2007;57:A290.

    Google Scholar 

  14. 14.

    Padwal R, Kezouh A, Levine M, et al. Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes. 2007;31:1567–70.

    Article  CAS  Google Scholar 

  15. 15.

    Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;337:1194–9.

    Article  Google Scholar 

  16. 16.

    Williamson DF. Pharmacotherapy for obesity. JAMA. 1999;281:278–80.

    Article  CAS  PubMed  Google Scholar 

  17. 17.

    Melissas J, Mouzas J, Filis D, et al. The intragastric balloon—smoothing the path to bariatric surgery. Obes Surg. 2006;16:897–902.

    Article  PubMed  Google Scholar 

  18. 18.

    Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.

    Article  CAS  PubMed  Google Scholar 

  19. 19.

    Roman S, Napoleon B, Mion F, et al. Intragastric balloon for “non-morbid” obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2004;14:539–44.

    Article  PubMed  Google Scholar 

  20. 20.

    Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14:991–8.

    Article  PubMed  Google Scholar 

  21. 21.

    Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg. 2001;88:1245–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Potential Conflicts of Interests

The authors declare that they have no conflict of interest.

Funding

No funding was obtained for this work.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jean-Marc Dumonceau.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dumonceau, JM., François, E., Hittelet, A. et al. Single vs Repeated Treatment with the Intragastric Balloon: A 5-Year Weight Loss Study. OBES SURG 20, 692–697 (2010). https://doi.org/10.1007/s11695-010-0127-x

Download citation

Keywords

  • Obesity
  • Gastrointestinal endoscopy
  • Gastric balloon
  • Weight loss